Bor-Wen Wu

Antiviral and resistance studies of AG1343, an orally bioavailable inhibitor of human immunodeficiency virus protease

Amy K. Patick, Hongmei Mo, Martin Markowitz et al. · Antimicrobial Agents and Chemotherapy · 1996 · 209 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma

Peter W. Szlosarek, Jeremy Steele, Luke Nolan et al. · JAMA Oncology · 2016 · 202 citations · Full text

Medicine, Oncology, Pharmacology +16

Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

Michael D. Allen, Phuong Luong, Chantelle Hudson et al. · Cancer Research · 2013 · 156 citations

Medicine, Oncology, Urology +17

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Patrick A. Ott, Richard D. Carvajal, Neeta Pandit‐Taskar et al. · Investigational New Drugs · 2012 · 146 citations · Full text

Medicine, Clinical Sciences, Oncology +14

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers

Emma Beddowes, James Spicer, Pui Ying Chan et al. · Journal of Clinical Oncology · 2017 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15